BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297,674 | -10.9% | 2,740 | -11.5% | 0.18% | -8.6% |
| Q2 2023 | $334,259 | +62.1% | 3,097 | +87.1% | 0.20% | +75.2% |
| Q1 2023 | $206,163 | -15.6% | 1,655 | +1.8% | 0.11% | -11.7% |
| Q4 2022 | $244,258 | +3.5% | 1,626 | -6.9% | 0.13% | +36.2% |
| Q3 2022 | $236,000 | -8.2% | 1,747 | +1.5% | 0.09% | -1.1% |
| Q2 2022 | $257,000 | +12.2% | 1,721 | +28.1% | 0.10% | -6.9% |
| Q1 2022 | $229,000 | -33.8% | 1,344 | 0.0% | 0.10% | -22.1% |
| Q4 2021 | $346,000 | -38.9% | 1,344 | -35.2% | 0.13% | -47.4% |
| Q3 2021 | $566,000 | +11.6% | 2,073 | -8.4% | 0.25% | +19.7% |
| Q2 2021 | $507,000 | -19.7% | 2,264 | -60.8% | 0.21% | -22.1% |
| Q1 2021 | $631,000 | +37.8% | 5,779 | +2.8% | 0.27% | +40.5% |
| Q4 2020 | $458,000 | +3.9% | 5,621 | -11.7% | 0.19% | -17.7% |
| Q3 2020 | $441,000 | -8.3% | 6,363 | -11.8% | 0.23% | +1.3% |
| Q2 2020 | $481,000 | – | 7,212 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |